Adverse Respiratory Events Associated With Hypnotics Use in Patients of Chronic Obstructive Pulmonary Disease: A Population-Based Case-Control Study
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Insomnia is prevalent in patients with chronic obstructive pulmonary disease (COPD).We conducted a population-based case-control study to evaluate the effects of hypnotics on the risk of adverse respiratory events in patients with COPD.The case-control study was investigated using data retrieved from the Taiwan National Health Insurance Research Database. Patients with newly diagnosed adverse respiratory events (pneumonia, COPD with acute exacerbation, acute respiratory failure, and cardiopulmonary arrest) were included in the case group. Patients with COPD and no history of adverse respiratory events were randomly selected for the control group, which was frequency-matched with the case group according to index date, age (per 10 years), and sex. Patients who had used hypnotics within 1 month meant active users. The odds ratios (ORs) and 95% confidence intervals (CIs) of were calculated using univariable and multivariable logistic regression models.Most of the study participants were male (71.6%), and the mean ages of the participants in the case and control groups were 69.2 (±12.4) and 67.5 (±12.3) years, respectively. After potential confounding factors were adjusting for, the adjusted ORs of adverse respiratory events were 12.0 for active users of benzodiazepines (95% CI, 8.11-17.6) and 10.5 for active users of nonbenzodiazepines (95% CI, 7.68-14.2) compared with the adjusted ORs of those who never used hypnotics.The results of this epidemiological study suggested that hypnotics increased the risk of adverse respiratory events in patients with COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161 · cited 1×
“Despite improving sleep quality, these drugs involve detrimental risks, such as ataxia, falls, and cognitive impairment, in elderly patients.(14) Patients with COPD for various reasons, including treatment on, and anxiety.”
BackgroundBehavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999) · JAMA · doi:10.1001/jama.281.11.991 · Cited by 1,095 · cited 1×
“techniques, biofeedback, and cognitive behavior therapy, for patients with COPD experiencing insomnia.(28,35,36) The risk of adverse respiratory events increased with the increase in CCI scores, a finding that is consistent with those of previous studies.”
Result
Cited by
Brandt, J., & Leong, C. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0207-7 · Cited by 356
Risks of Zolpidem among Patients with Chronic Obstructive Pulmonary Disease
Castaneda, J. M., Hee Wai, T., Spece, L. J., Duan, K. I., Leonhard, A., Griffith, M. F., Plumley, R., Palen, B. N., Feemster, L. C., Au, D. H., et al. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202307-654oc · Cited by 6
El-Solh, A. A., Lawson, Y., & Wilding, G. E. (2023) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s430609 · Cited by 5
“14,35 The respiratory adverse effects attributed to the use of hypnotics were recently challenged by Lu et al 33 while studying the impact of hypnotics on COPD patients with insomnia.”
BackgroundInfluential
Metadata
- Authors
- Chung, W.-S., Lai, C.-Y., Lin, C.-L., & Kao, C.-H.
- Venue
- Medicine
- Published
- 2015-07
- Volume
- 94
- Issue
- 27
- Pages
- e1110
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W895835895
- Cited by
- 42
- References
- 2
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adverse Respiratory Events Associated With Hypnotics Use in Patients of Chronic Obstructive Pulmonary Disease: A Population-Based Case-Control Study. https://app.cochat.ai/papers/10.1097/md.0000000000001110
- The paper
- Chung, W.-S., Lai, C.-Y., Lin, C.-L., & Kao, C.-H. (2015). Adverse Respiratory Events Associated With Hypnotics Use in Patients of Chronic Obstructive Pulmonary Disease: A Population-Based Case-Control Study. Medicine. https://doi.org/10.1097/md.0000000000001110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.